The Latest Cardiac and Vascular News
ATLANTA, Oct. 22, 2025 /PRNewswire/ — Nyra Medical, a leading innovator in structural heart therapies, announced today the initiation of its first-in-human clinical study evaluating its novel Cardiac Leaflet Enhancer (CARLEN™) System in patients with functional (secondary) mitral…
ATLANTA, May 27, 2025 /PRNewswire/ — Nyra Medical, a leading innovator in structural heart therapies, today announced two key executive appointments that further solidify the company’s momentum as it advances its revolutionary Cardiac Leaflet Enhancer (CARLEN) System toward clinical and…
Financing co-led by Vensana Capital and a Large, Global Medical Device Company Use of Proceeds to Advance Development of a Novel Catheter-based Solution for Mitral Regurgitation ATLANTA, Nov. 23, 2022 /PRNewswire/ — Nyra Medical, Inc., a medical device company that is developing a novel transcatheter mitral valve repair technology, today announced the […]
